Methods: We identified 74 single CBU Tx of patients age 0-12 years old, facilitated through the Be The Match Registry from Sept 2009 to Aug 2012 with a Tx cell dose >20 x 10^7 TNC/kg. The CBU searches were reviewed to determine whether another suitable CBU (10-20 x 10^7 TNC/kg and equivalent or better low resolution HLA-A, B, C, high resolution -DRB1) was available for that patient. A TNC threshold for CBU suitability for a potential adult patient of 178 x 10^7 was established based on the historical median weight of 71kg for adult CBU Tx recipients.
Results: Of the 74 Tx evaluated, 58 (78%) units had a minimum TNC of 178 x 10^7 (range 178-452), large enough for the median weight adult patient. In 48 of the 58 cases a suitable CBU with 10-20 TNC/kg was available on the search with an equivalent or better HLA match and 23% of the time the lower TNC CBU was a better HLA match. If the lower TNC CBUs had been selected for this cohort, the median cell dose would decrease from 28.7 to 11.5 TNC/kg.
Conclusions: The number of CBU in the registry that meet the median adult patient dose of 178 x 10^7 TNC is 16,494 (7%) CBU compared to 234,292 available for peds Tx. Transplant practice is often to take the largest CBU available for a patient, with consideration of HLA match differing between centers. This study shows that CBU used in Tx for children can exceed 20 x 10^7 TNC/kg. These CBU have a large TNC and could be suitable for adolescent or adult single cord transplantation. Although 74 CBU Tx correspond to a small proportion of total peds (age 12 and under) single CBU Tx during this timeframe (n=951), these units may offer the only opportunity for an adult patient. With a limited number of CBUs achieving high TNC available for adult patients, consideration of the ethics of providing a young patient with an adequate TNC CBU (e.g. 10-20 x 10^7 TNC/kg) vs the largest TNC CBU will continue to confront the community. Centers should consider selecting a CBU with smaller, yet still substantial cell dose, particularly when it’s a better HLA match. Future outcomes research is needed to elucidate the optimal TNC or identify a maximum threshold recommendation for guidance in CBU Tx in small children prior to a policy being implemented.